Diagnosis of attention deficit hyperactivity disorder: Much ado about something

Israel Medical Association Journal

Volumn 13, Issue 9, 2011, Pages 571-574

  Berger, Itai ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Attention deficit hyperactivity disorder; Bias; Diagnosis

Indexed keywords

ANTISOCIAL BEHAVIOR; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; COMORBIDITY; CONTINUOUS PERFORMANCE TEST; CULTURAL BIAS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MARKER GENE; QUESTIONNAIRE; REVIEW; SUBSTANCE ABUSE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIAS (EPIDEMIOLOGY); CHILD; COMORBIDITY; GENETIC MARKERS; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 80052999296     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Skounti M, Philalithis A, Galanakis E. Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J Pediatr 2007; 166: 117-23.
2. American Academy of Pediatrics. Committee on quality improvement, subcommittee on attention-deficit/hyperactivity disorder. Clinical practice guideline: diagnosis and evaluation of the child with ADHD. Pediatrics 2000; 105: 1158-70.
3. Berger I, Dor T, Nevo Y, Goldzweig G. Attitudes toward ADHD treatment: parents and children perspectives. J Child Neurol 2008; 23: 1036-42.
4. Wallis D, Russell HF, Muenke M. Genetics of attention deficit/hyperactivity disorder [Review]. J Pediatr Psychol 2008; 33: 1085-99.
5. Furman LM. Attention-deficit hyperactivity disorder (ADHD): does new research support old concepts? J Child Neurol 2008; 23: 775-84.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-IV-TR). 4th edn. Washington, DC: American Psychiatric Association, 2000.
7. Rader R, McCauley L, Callen EC. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. Am Fam Physician 2009; 79: 657-65.
8. Rousseau C, Measham T, Bathiche-Suidan M. DSM IV, culture and child psychiatry. J Can Acad Child Adolesc Psychiatry 2008; 17: 69-75.
9. Schonwald A, Lechner E. Attention deficit/hyperactivity disorder: complexities and controversies. Curr Opin Pediatr 2006; 18: 189-95.
10. Castellanos F, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3: 617-28.
11. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention deficit hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-23.
12. Rommelse NN. Endophenotypes in the genetic research of ADHD over the last decade: have they lived up to their expectations? Expert Rev Neurother 2008; 8: 1425-9.
13. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007; 96: 1269-74.
14. Waldman ID. Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1347-56.
15. Beauchaine TP, Neuhaus E, Brenner SL, Gatzke-Kopp L. Ten good reasons to consider biological processes in prevention and intervention research. Dev Psychopathol 2008; 20: 745-74.
16. Millichap JG. Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics 2008; 121: e358-65.
17. American Academy of Pediatrics. Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention deficit/ hyperactivity disorder. Pediatrics 2001; 108: 1033-44.
18. Suhr J, Zimak E, Buelow M, Fox L. Self-reported childhood attention deficit/ hyperactivity disorder symptoms are not specific to the disorder Compr Psychiatry 2009; 50: 269-75.
19. Nichols SL, Waschbusch DA. A review of the validity of laboratory cognitive tasks used to assess symptoms of ADHD. Child Psychiatry Hum Dev 2004; 34: 297-315.
20. Edwards MC, Gardner ES, Chelonis JJ, Schulz EG, Flake RA, Diaz PF. Estimates of the validity and utility of the Conner's CPT in the assessment of inattentive and/or hyperactive impulsive behaviors in children. J Abnorm Child Psychol 2007; 35: 393-404.
21. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 2001; 13: 326-35.
22. Wherry JN, Paal N, Jolly JB, et al. Concurrent and discriminant validity of the Gordon Diagnostic System: a preliminary study. Psych School 1993; 30: 29-36.
23. Trommer BL, Hoeppner JB, Lorber R, Armstrong K. Pitfalls in the use of a continuous performance test as a diagnostic tool in attention deficit disorder. J Dev Behav Pediatr 1988; 9: 339-45.
24. Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/ hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64: 1145-52.
25. Langley K, Fowler T, Ford T, et al. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry 2010; 196: 235-40.
26. Fogelman Y, Kahan E. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel-a controversial issue. IMAJ Isr Med Assoc J 2001; 3: 925-7.